| Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study P Hovind, L Tarnow, P Rossing, M Graae, I Torp, C Binder, HH Parving Bmj 328 (7448), 1105, 2004 | 548 | 2004 |
| Progression of nephropathy in type 2 diabetic patients K Rossing, PK Christensen, P Hovind, L Tarnow, P Rossing, HH Parving Kidney international 66 (4), 1596-1605, 2004 | 494 | 2004 |
| Progression of diabetic nephropathy P Hovind, P Rossing, L Tarnow, UM Smidt, HH Parving Kidney international 59 (2), 702-709, 2001 | 466 | 2001 |
| Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes P Hovind, L Tarnow, K Rossing, P Rossing, S Eising, N Larsen, C Binder, ... Diabetes care 26 (4), 1258-1264, 2003 | 455 | 2003 |
| Serum uric acid as a predictor for development of diabetic nephropathy in type 1 diabetes: an inception cohort study P Hovind, P Rossing, L Tarnow, RJ Johnson, HH Parving Diabetes 58 (7), 1668-1671, 2009 | 307 | 2009 |
| Urinary proteomics for early diagnosis in diabetic nephropathy P Zürbig, G Jerums, P Hovind, RJ MacIsaac, H Mischak, SE Nielsen, ... Diabetes 61 (12), 3304-3313, 2012 | 294 | 2012 |
| Elevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetes L Tarnow, P Hovind, T Teerlink, CDA Stehouwer, HH Parving Diabetes care 27 (3), 765-769, 2004 | 283 | 2004 |
| Elevated vascular endothelial growth factor in type 1 diabetic patients with diabetic nephropathy P Hovind, L Tarnow, PB Oestergaard, HH Parving Kidney International 57, S56-S61, 2000 | 200 | 2000 |
| The Copenhagen Sarcopenia Study: lean mass, strength, power, and physical function in a Danish cohort aged 20–93 years C Suetta, B Haddock, J Alcazar, T Noerst, OM Hansen, H Ludvig, ... Journal of cachexia, sarcopenia and muscle 10 (6), 1316-1329, 2019 | 189 | 2019 |
| Urinary connective tissue growth factor excretion correlates with clinical markers of renal disease in a large population of type 1 diabetic patients with diabetic nephropathy TQ Nguyen, L Tarnow, S Andersen, P Hovind, HH Parving, ... Diabetes care 29 (1), 83-88, 2006 | 181 | 2006 |
| Vitamin D levels, microvascular complications, and mortality in type 1 diabetes C Joergensen, P Hovind, A Schmedes, HH Parving, P Rossing Diabetes care 34 (5), 1081-1085, 2011 | 169 | 2011 |
| Urinary liver-type fatty acid-binding protein predicts progression to nephropathy in type 1 diabetic patients SE Nielsen, T Sugaya, P Hovind, T Baba, HH Parving, P Rossing Diabetes care 33 (6), 1320-1324, 2010 | 160 | 2010 |
| Mannose-binding lectin as a predictor of microalbuminuria in type 1 diabetes: an inception cohort study P Hovind, TK Hansen, L Tarnow, S Thiel, R Steffensen, A Flyvbjerg, ... Diabetes 54 (5), 1523-1527, 2005 | 156 | 2005 |
| Spleen emptying and venous hematocrit in humans during exercise M Laub, K Hvid-Jacobsen, P Hovind, IL Kanstrup, NJ Christensen, ... Journal of Applied Physiology 74 (3), 1024-1026, 1993 | 156 | 1993 |
| Genetic variation in the renin-angiotensin system and progression of diabetic nephropathy P Jacobsen, L Tarnow, B Carstensen, P Hovind, O Poirier, HH Parving Journal of the American Society of Nephrology 14 (11), 2843-2850, 2003 | 134 | 2003 |
| Evolving strategies for renoprotection: diabetic nephropathy HH Parving, P Hovind, K Rossing, S Andersen Current Opinion in Nephrology and Hypertension 10 (4), 515-522, 2001 | 132 | 2001 |
| Remission and regression in the nephropathy of type 1 diabetes when blood pressure is controlled aggressively P Hovind, P Rossing, L Tarnow, UM Smidt, HH Parving Kidney international 60 (1), 277-283, 2001 | 132 | 2001 |
| Plasma N-terminal pro-B-type natriuretic peptide and mortality in type 2 diabetes L Tarnow, MA Gall, BV Hansen, P Hovind, HH Parving Diabetologia 49, 2256-2262, 2006 | 131 | 2006 |
| Irbesartan treatment reduces biomarkers of inflammatory activity in patients with type 2 diabetes and microalbuminuria: an IRMA 2 substudy F Persson, P Rossing, P Hovind, CDA Stehouwer, C Schalkwijk, L Tarnow, ... Diabetes 55 (12), 3550-3555, 2006 | 125 | 2006 |
| Endothelial dysfunction and inflammation predict development of diabetic nephropathy in the Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria (IRMA 2) study F Persson, P Rossing, P Hovind, CDA Stehouwer, CG Schalkwijk, ... Scandinavian journal of clinical and laboratory investigation 68 (8), 731-738, 2008 | 120 | 2008 |
